About Company

Our mission: To provide a smarter way to relieve severe pain
immediately with deep and long-lasting results.

Our story

BioWave® is a non-opioid, FDA cleared, patented, Smarter Pain Blocking Technology® designed to block pain at the source. We offer a comprehensive approach to personalized care focused on outcomes for each patient. Our technology is safe and effective with no drugs and no side effects. It is portable and easy to use with one-button control. BioWave® products are widely prescribed to people with acute, chronic and post-operative pain.

History

BioWave’s proprietary technology was developed and born in professional sports in conjunction with the New York Giants football team through a clinical study treating pain from acute and chronic injuries in professional football players. This study and others were the basis for our first FDA clearance.
After getting its first FDA clearance, BioWave built a strong customer base in professional, collegiate, and Olympic sports which continues to this day. Professional & Collegiate Athletic trainers consider BioWave a go-to modality to help their athletes manage pain through their recovery and rehabilitation from sports related injuries. In 2017 BioWave began helping patients of the Veterans Administration, Department of Labor and Active Military manage their acute and chronic pain conditions. To date BioWave has been prescribed by over 140 Federal Healthcare VA Сlinics resulting in a number of white papers and a published study that document successful outcomes for patients who used BioWave. BioWave’s prescription products have been prescribed to over 500 professional athletes and are used by over 105 professional sports teams in the NFL, MLB, NBA, NHL and MLS and by over 140 college sports teams.

Leadership

Lance Lundberg

Chairman of the Board

Bradford Siff

Founder & President

Rob Wolter

Chief Executive Officer

Management

Tom Keating

Director of Finance

Tia Cavone

Senior Director of Operations

Renee Cody

Senior Director of Corporate Development

Ania Kuniej

Director of Marketing

Tony Queiroga

Senior Director of Government Sales

Tijana Radinkovic

Director of Customer Service

BioWave is Changing
Lives every day

Lance Lundberg

Chairman of the Board

Mr. Lundberg has over 40 years of experience creating and running successful businesses. Twice on the Inc 500 list and awarded the Entrepreneur of the year Award by Ernst and Young/Merrill Lynch. Mr. Lundberg completed three public exits across companies founded or co-founded: Icon International (Omnicom), Resolute Digital (Interpublic), and Verde Energy (Spark Energy).

His current leadership roles include LOOK Optic, BioWave, FRA gyms (Pure Barre), Longitude73, and Kitesail LLC. He was the past Chair and Board member of Silver Hill Psychiatric Hospital for 17 years, a member YPO Gold Greenwich and Palm Beach, and graduated Yale Summa BS and Harvard Business School.

Brad Siff

Founder & President

Brad is the founder of BioWave and a member of the Board of Directors. He is a skilled business leader and provides the guiding vision and strategic direction for the company. Brad manages new product development, R&D, clinical studies and applications, reimbursement strategy, quality, regulatory, contract manufacturing, government affairs and corporate finance. His original concept for BioWave’s signal technology came from an inspiration he had while working as the Chief Operating Officer at a prior medical device company. Brad also worked for 7 years as Senior Vice President of Mergers & Acquisitions for Daiwa Securities with a focus on the Medical Device Industry.

Brad received undergraduate and Master’s degrees from Cornell Engineering and an MBA from Cornell’s Johnson Graduate School of Management. Brad’s Master’s Thesis was focused on a project for the Hospital for Special Surgery in New York City. In his spare time, Brad is a fitness junkie and has been known to rip tremendous topspin on a tennis or paddle ball. He is an artist, photographer, and fond of traveling, skiing, food and wine.